Chronic Widespread Pain
FIBROLINE
Managing Chronic Widespread Pain With FIBROLINE
1 other identifier
interventional
50
1 country
1
Brief Summary
Cognitive-behavioral treatments have proven effective in helping people with chronic pain. However, due to the limited availability of trained clinicians, many young people with chronic pain problems do not benefit from them. In order to overcome the shortage of clinicians researchers have begun to develop treatment programs that could be self-administered by smartphones. Although this is a step in the right direction, it is equally true that it also encloses a problematic issue. Namely, a large number of experienced clinicians would still be needed to oversee the functioning of these programs, and it does not seem likely that they will be available within a short time, at least in certain countries. The objectives of this project are (1) to develop a web platform (iPAINs) to assist the clinician in the process of (a) creating and (b) administering cognitive-behavioral treatments for the management of chronic pain in adolescents and young adults, and (2) study the efficacy of a self-administered cognitive-behavioral treatment for young people with fibromyalgia or chronic widespread pain, developed and administered through iPAINs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-pain
Started Jan 2019
Typical duration for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2017
CompletedStudy Start
First participant enrolled
January 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2021
CompletedFirst Posted
Study publicly available on registry
June 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedJune 28, 2021
June 1, 2021
2.4 years
January 11, 2017
June 18, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Average Pain Intensity
Participants are asked to report three domains of pain intensity (i.e., average, worst, and current) using 0-10 numerical rating scales (NRS-11) with 0 meaning "No pain" and 10 meaning "Very much pain". A composite score (consisting of the mean of the individuals' three pain intensity scores) will be used as a measure of pain intensity.
through study completion, an average of 1 year
Sleep Quality
Questionnaire used: Pittsburgh Sleep Quality Index (PSQI). The PSQI assesses sleep quality over the past month. The responder is requested to answer 19 questions that assess a variety of factors related to sleep quality. These 19 items generate seven component scores (each weighted equally on a 0-3 scale): sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping medication and daytime dysfunction. The seven component scores are summed into a global PSQI score, which has a range of 0-21; higher score indicates worse sleep quality. This questionnaire includes five questions for the roommate of the responder which are used for clinical information and will not be included in this study.
through study completion, an average of 1 year
Anxiety
Questionnaire used: The Spanish version of Patient-Reported Outcomes Measurement the Information System short form for Anxiety (PROMIS Short Form v1.0 - Anxiety 8a). It has 8 items asking about the frequency of physiological arousal, somatic symptoms and concerns in the past week. Participants will be asked to rate the frequency with which they experienced 8 anxiety symptoms in the last 7 days using a 5-point Likert scale (1= "Never"; 2 = "Almost never"; 3 = "Sometimes"; 4 = "Often"; 5 = "Almost always"). PROMIS-Anxiety has shown to provide a reliable measure of anxiety symptoms with ethnically diverse groups
through study completion, an average of 1 year
Depression
Questionnaire used: The Spanish version of the PROMIS short form for Depression (PROMIS Short Form v1.0 - Depression 8a). This scale consists of 8 items that assesses the frequency of affective and cognitive manifestations of depression in the past week. The PROMIS Short Form v1.0 has been shown to provide a reliable measure of depressive symptoms when used with women with fibromyalgia
through study completion, an average of 1 year
Fatigue
Questionnaire used: the Silhouettes Fatigue Scale (SFS) The SFS is a visual scale that has six human silhouettes showing an increasing level of fatigue from left to right, from "no fatigue" to "a lot of fatigue". SFS has shown to provide valid and reliable information when used with adults.
through study completion, an average of 1 year
Study Arms (1)
Treatment
EXPERIMENTALA Smartphone self-administered cognitive-behavioral based intervention
Interventions
Treatment includes a smartphone-delivered CBT program designed to improve the quality of life of individuals with chronic pain. The treatment is condensed in nine weeks, and contains the following modules or units of treatment: sleep quality, anxiety management, pain coping, medication use, physical conditioning, mood regulation, problem solving, decision-making and relationships with others. All the content and settings are written in Spanish.
Eligibility Criteria
You may qualify if:
- Diagnosis of fibromyalgia or chronic widespread pain
- Capable of understanding, reading and writing in Spanish
You may not qualify if:
- Physical disabilities that interfered in the use of a Smartphone
- Severe cognitive impairments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Rovira i Virgililead
- Ministerio de Economía y Competitividad, Spaincollaborator
- Obra Social de La Caixacollaborator
Study Sites (1)
Chair in Pediatric Pain - Universitat Rovira i Virgili
Tarragona, 43007, Spain
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 11, 2017
First Posted
June 28, 2021
Study Start
January 22, 2019
Primary Completion
June 15, 2021
Study Completion
September 30, 2021
Last Updated
June 28, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share